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Section 1
A 75-year-old man presented to the emergency department with a 1-year history of 66-pound
weight loss and alternating bowel habits. He was admitted to the hospital, where he underwent
several examinations to investigate the presence of a malignancy. A colonoscopy, a gastroscopy,
an ultrasound of the abdomen, and a contrast-enhanced CT scan of thorax and abdomen did
not detect any neoplasia. The only ﬁndings consisted of a prostatic hypertrophy and a basal
pleural–parenchymal hyperdensity in the left lung, which was described as the result of an
infective process. Neoplastic markers CA19.9, carcinoembryonic antigen, neuron-speciﬁc
enolase, and α-fetoprotein were also negative. Wide-spectrum blood tests were unremarkable,
except for hypogammaglobulinemia and elevated β2 microglobulin.
Upon a more thorough collection of the patient’s history and examination, progressive stiﬀness
and slowness of movements were reported to have appeared a few months before, along with
a longer history of mood depression, apathy, hyporexia, hyposmia, constipation, micrographia,
dysphagia, hypophonia, and sleep disturbances including sleeplessness and REM sleep behavior
disorder.
A neurologic examination of the motor system revealed a symmetric and severe plastic hy-
pertonia in the trunk and all 4 extremities with cogwheel rigidity at the wrists and marked
bradykinesia. In the cranial district, hypomimia, hypophonia, and upward gaze limitation were
noticed. Deep tendon reﬂexes were normal on all 4 limbs. No tremor was recorded. Inducible
small-amplitude polyminimyoclonus could be elicited in the upper extremities. The patient
could stand aided and walked a few steps with a slow and normal-base gait. Findings on the
remainder of the neurologic examination were unremarkable. Family history was negative for
neurodegenerative diseases, although a sister had multiple sclerosis and a daughter had
depression.
Questions for consideration:
1. What are the main neurologic systems involved?
2. What medical conditions could be considered in the diﬀerential diagnosis?
GO TO SECTION 2
From the Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation (E.F., E.M., G.B., N.B., M.C.S., A.D.F.), Angelo Bianchi Bonomi Hemophilia
and Thrombosis Centre (B.F.), and Internal Medicine, Department of Pathophysiology and Transplantation (S.A.), IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico,
University of Milan, Italy.
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
572 Copyright © 2018 American Academy of Neurology
Copyright ª 2018 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Section 2
The patient’s clinical presentation displayed an involvement
of basal ganglia and limbic circuits.
The ﬁndings of truncal and limb rigidity, severe diﬀuse
bradykinesia, hypophonia, mask-like facial appearance,
and micrographia should direct the diagnostic hypotheses
towards a parkinsonian syndrome. This diagnosis is
reinforced by the presence of several nonmotor symptoms
(i.e., hyposmia, mood depression, sleep disturbances,
constipation, weight loss). The age at onset and the
clinical presentation may be compatible with an idiopathic
form of Parkinson disease (PD) or an atypical parkin-
sonism, including multiple system atrophy type P
(MSA-P), progressive supranuclear palsy, basal ganglia
calciﬁcation syndrome, or Perry syndrome. The lack of a
dominant pattern of inheritance in the family made
the latter hypothesis less likely. Given its relatively
high prevalence among causes of extrapyramidal dis-
orders, the possibility of a vascular parkinsonism should
not be discarded either. Nevertheless, the presence
of nonmotor symptoms and the lack of cardiovascular
risk factors and of a lower limb–dominant parkinsonism
with gait abnormalities are not suggestive of a vascular
etiology.
The history of weight loss, even without the ﬁnding of
a neoplasm, and the subacute onset of symptoms may still
suggest a more complex paraneoplastic or dysimmune neu-
rologic syndrome. In this perspective, stiﬀ-person syndrome,
a form of parkinsonism and truncal rigidity that may occur in
concomitance with a tumor, was considered in the diﬀerential
diagnosis.
The rapid progression and worsening of symptoms and the
presence of mood changes and cognitive decline may also
suggest a prion disease. Cortical myoclonus, usually periodic
and pseudorhythmic, is also a feature of prion-related ence-
phalopathies, but it is worth noticing that polyminimyoclonus,
as noticed in this case, is often found in synucleinopathies (e.g.,
PD, MSA-P, dementia with Lewy bodies).1
Questions for consideration:
1. What further examinations should be prescribed?
2. What therapeutic intervention could be adopted to help
in the diagnostic process?
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Section 3
The patient underwent a CT scan of the brain, which excluded
the presence of basal ganglia calciﬁcation. A brain MRI was
performed revealing a few punctiform T2 hyperintense
lesions in bihemispheric white matter of probable vascular
origin. However, basal ganglia appeared to be spared. T2-
weighted and ﬂuid-attenuated inversion recovery (FLAIR)
sequences showed a hyperintense signal in bilateral mesial
temporal lobes (ﬁgure, A). T1-weighted images showed mild
bilateral hippocampal atrophy (ﬁgure, B). EEG was normal.
To further investigate the paraneoplastic hypothesis, the patient
underwent a total body FDG-PET scan, which revealed a hyper-
ﬁxation of pulmonary bases and a few thoracic lymph nodes,
which were again interpreted as basal pneumonia, for which the
patient was started on antibiotic therapy. Bronchoscopy was
performed to better investigate the radiologic abnormalities in the
lung bases, without evidence of malignant cells. FDG-PET cere-
bral scans showed a diﬀuse cortical hypermetabolism, with
a stronger signal in the basal ganglia (ﬁgure, C and D).
During hospitalization, the patient developed acute leukopenia,
which regressed spontaneously in a few days. For a full charac-
terization of the hematologic status of hypogammaglobulinemia,
elevated β2microglobulin, and the recent episode of leukopenia,
bone marrow biopsy was performed, with the detection of
chronic B-cell leukemia. Concomitantly, the patient presented
an acute episode of gastroparesis, followed by hypovolemic
shock, which was treated with a ﬂuid load, and supraventricular
tachycardia, which regressed spontaneously.
Meanwhile, the patient was started on ex adjuvantibus therapy
with levodopa and baclofen and soon showed a moderate
decrease of muscular rigidity and bradykinesia and a good
response on hypomimia.
Questions for consideration:
1. Given this new evidence, what is the most probable
diagnostic orientation?
2. What examinations would be of additional value to the
diagnostic hypothesis?
GO TO SECTION 4
Figure Structural and functional brain imaging
(A) Axial fluid-attenuated inversion recovery image shows
hyperintense signal in left mesial temporal lobe. (B) Coro-
nal T1-weighted image shows mild bilateral hippocampal
atrophy. (C, D) Axial and coronal brain FDG-PET images
show basal ganglia and cortical hypermetabolism.
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Section 4
The detection of an increased ﬁxation of FDG in the cerebral
cortex and, particularly, in the basal ganglia may be suggestive
of an autoimmune disorder with involvement of the CNS.
The occurrence of gastroparesis and tachyarrhythmia suggests
an impairment of the autonomic nervous system. To dis-
criminate the central or peripheral nature of dysautonomia,
EMG was performed. Results showed a prominent chronic
sensory-motor axonal polyneuropathy, which could be con-
sidered the cause of autonomic dysfunction.
In order to rule out possible autoimmune processes, a lumbar
puncture was performed. CSF pressure, cell count, protein, and
glucose levels were normal. Oligoclonal bands were absent in
serum and CSF. A wide-spectrum antibody assay was con-
ducted on CSF and serum to evaluate the presence of auto-
antibodies associated with paraneoplastic neurologic
syndromes (i.e., antibodies anti-Hu, Yo, Ri, amphiphysin,Ma1/
2, CV2, SOX1, Tr[DNER], ZIC4, CASPR2, leucine-rich
glioma-inactivated 1 [LGI1], GAD65, and GlyR). Serology
results showed the presence of anti-LGI1 antibodies in serum.
The patient was started on steroidal therapy, ﬁrst with IV
methylprednisolone 1 g for 5 days, followed by oral admin-
istration of lower doses of prednisone. After initial improve-
ment of bradykinesia, rigidity, hypophonia, and facial
mimicry, the clinical presentation remained stable, with an
important parkinsonian syndrome. The patient’s general
condition worsened rapidly upon reduction of steroidal
therapy and led to death a few weeks later, probably due to an
exacerbation of the underlying leukemia.
Discussion
Anti-LGI1 antibodies–associated encephalitis is an autoim-
mune disorder usually characterized by epileptic seizures,
memory deterioration, behavioral changes, sleep dis-
turbances, and hyponatremia.2 Few cases of unusual pre-
sentation of LGI1-related syndrome have been described to
be accompanied by a multitude of movement disorders, in-
cluding prominent akinetic-rigid parkinsonism,3 progressive
encephalomyelitis with rigidity and myoclonus,4 chorea,5
dystonia, and neuromyotonia.6
In the diagnostic reasoning, the history of weight loss, rapid and
symmetric parkinsonism, and behavioral changes were red ﬂags
for a paraneoplastic or dysimmune encephalopathy. Cerebral
imaging was supportive of an autoimmune process, with the
evidence of hyperﬁxation of FDG in basal ganglia. Brain MRI
scans showing hippocampal atrophy and increased FLAIR/T2
signal in mesial temporal cortices were consistent with LGI1
encephalitis.7,8 The ﬁnding of LGI1 antibodies in serum con-
ﬁrmed the immune-mediated etiology of the syndrome.
A few case reports have found that LGI1 encephalitis is mainly
nonparaneoplastic, with negativity of tumor markers and ra-
diologic examinations.8,9 In this case, it was speculated that
the severe loss of weight could be attributed either to chronic
B-cell leukemia or to hyporexia inscribed in the context of
mood depression.
LGI1 encephalitis has been described to be responsive to im-
munotherapy: a combination of high-dose corticosteroids, IV
immunoglobulin (IVIg), and plasma exchange seems to bemore
eﬀective than corticosteroid monotherapy in improving the de-
gree of recovery.10 In this case, methylprednisolone only was
administered, since the presence of hypogammaglobulinemia
and the history of a previous cardiac arrhythmia contraindicated
the use of IVIg and plasmapheresis.
The case described here falls into an atypical presentation of
LGI1 encephalitis, due to the absence of epileptic seizures and
the prevalence of parkinsonism, mood depression, and dys-
autonomic neuropathy, along with the possible association
with a systemic malignancy.
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